EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Assembly Biosciences, Inc. (ASMB) EBITDA Margin data is not available.
| Income Statement Financials | |
$9.42M |
|
$-8.82M |
|
-- |
|
$9.42M |
|
$19.36M |
|
$-9.94M |
|
$1.12M |
|
$-8.82M |
|
$-8.82M |
|
$-8.82M |
|
$-8.82M |
|
$-8.82M |
|
$-8.82M |
|
$-9.94M |
|
$-10.42M |
|
7.51M |
|
7.51M |
|
$-1.17 |
|
$-1.17 |
|
| Balance Sheet Financials | |
$95.53M |
|
$0.25M |
|
$3.49M |
|
$99.02M |
|
$46.63M |
|
-- |
|
$25.25M |
|
$71.88M |
|
$27.13M |
|
$27.13M |
|
$27.13M |
|
7.62M |
|
| Cash Flow Statement Financials | |
$-23.44M |
|
$6.59M |
|
$1.92M |
|
$38.34M |
|
$23.41M |
|
$-14.93M |
|
$0.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-105.54% |
|
-105.54% |
|
|
EBITDA Margin |
-- |
-93.62% |
|
-93.62% |
|
$-23.44M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
-- |
|
-- |
|
-32.50% |
|
-32.50% |
|
-8.91% |
|
-32.50% |
|
$3.56 |
|
$-3.12 |
|
$-3.12 |
|